Metabolic risk factors in southern Taiwanese with impaired fasting glucose of 100 to 109 mg/dL

Metabolism: Clinical and Experimental

Volumn 56, Issue 4, 2007, Pages 528-532

  Hung, Wei Wen ^a   Chang, Chai Jan ^b   lee, Yau Jiunn ^c   Hsin, Shih Chieh ^b   Lin, Kun Der ^b   Hsieh, Ming Chia ^b   Hsiao, Pi Jung ^b   Shin, Shyi Jang ^b  

^a KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BODY MASS; BODY WEIGHT; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN EXPERIMENT; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; MALE; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; TAIWAN;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN;

EID: 33947288049     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.11.013     Document Type: Article

References (31)

1. Harris M.I., Hadden W.C., Knowler W.C., and Bennett P.H. International criteria for the diagnosis of diabetes and impaired glucose tolerance. Diabetes Care 8 (1985) 562-567
2. Gavin III J.R., Alberti K.G.M.M., Davidson M.B., DeFronzo R.A., et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
3. Unwin N., Shaw J., Zimmet P., and Alberti K.G.M.M. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19 (2002) 708-723
4. Hanefeld M., Temelkova-Kurktschiev T., Schaper F., Henkel E., Siegert G., and Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med 16 (1999) 212-218
5. Tominaga M., Eguchi H., Manaka H., Igarashi K., Kato T., and Sekikawa A. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22 (1999) 920-924
6. DECODE Study Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care 26 (2003) 688-696
7. DECODE Study Group. European Diabetes Epidemiology Group: glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161 (2001) 397-405
8. Genuth S., Alberti K.G., Bennett P., Buse J., DeFronzo R., and Kahn R. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26 (2003) 3160-3167
9. Schriger D.L., and Lorber B. Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic?. Diabetes Care 27 (2004) 592-595
10. Davidson M.B., Landsman P.B., and Alexander C.M. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care 26 (2003) 3329-3330
11. Glumer C., Jorgensen T., and Borch-Johnsen K. Prevalence of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26 (2003) 2335-2340
12. Balkau B., Eschwege E., Ducimetiere P., Richard J.L., and Warnet J.M. The high risk of death by alcohol-related diseases in subjects diagnosed as diabetic and impaired glucose tolerance: the Paris Prospective Study after 15 years of follow-up. J Clin Epidemiol 44 (1991) 465-474
13. Vaccaro O., and Riccardi G. Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition. Diabetes Care 28 (2005) 1786-1788
14. Ramachandran A., Snehalatha C., Kapur A., Vijay V., Mohan V., Das A.K., et al. High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 44 (2001) 1094-1101
15. Harris M.I., Flegal K.M., Cowie C.C., Eberhardt M.S., Goldstein D.E., Little R.R., et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21 (1998) 518-524
16. Borch-Johnsen K., Colagiuri S., Balkau B., Glumer C., Carstensen B., Ramachandran A., et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 47 (2004) 1396-1402
17. Tai E.S., Goh S.Y., Lee J.J., Wang M.S., Heng D., Hughes K., et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27 (2004) 1728-1734
18. Cheng C., Kushner H., and Falkner B.E. The utility of fasting glucose for detection of prediabetes. Metabolism 55 (2006) 434-438
19. Blake D.R., Meigs J.B., Muller D.C., Najjar S.S., Andres R., and Nathan D.M. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 53 (2004) 2095-2100
20. Wen C.P., Cheng T.Y., Tsai S.P., Hsu H.L., and Wang S.L. Increased mortality risks of pre-diabetes (impaired fasting glucose) in Taiwan. Diabetes Care 28 (2005) 2756-2761
21. Phillips L.S., Weintraub W.S., Ziemer D.C., Kolm P., Foster J.K., Vaccarino V., et al. All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dL: the Screening for Impaired Glucose Tolerance Study 1 (SIGT 1). Diabetes Care 29 (2006) 1405-1407
22. Festa A., D'Agostino Jr. R., Hanley A.J., Karter A.J., Saad M.F., and Haffner S.M. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53 (2004) 1549-1555
23. Hanefeld M., Koehler C., Fuecker K., Henkel E., Schaper F., and Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in impaired glucose tolerance for atherosclerosis and diabetes study. Diabetes Care 26 (2003) 868-874
24. Abdul-Ghani M.A., Tripathy D., and DeFronzo R.A. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29 (2006) 1130-1139
25. Carnevale Schianca G.P., Rossi A., Sainaghi P.P., Maduli E., and Bartoli E. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care 26 (2003) 1333-1337
26. Chen L.K., Lin M.H., Chen Z.J., Hwang S.J., Tsai S.T., and Chiou S.T. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese. Diabetes Res Clin Pract 71 (2006) 170-176
27. Davies M.J., Raymond N.T., Day J.L., Hales C.N., and Burden A.C. Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17 (2000) 433-440
28. Guerrero-Romero F., and Rodriguez-Moran M. Impaired glucose tolerance is a more advanced stage of alteration in the glucose metabolism than impaired fasting glucose. J Diabetes Complications 15 (2001) 34-37
29. Tripathy D., Carlsson M., Almgren P., Isomaa B., Taskinen M.R., Tuomi T., et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 49 (2000) 975-980
30. Weyer C., Bogardus C., Mott D.M., and Pratley R.E. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104 (1999) 787-794
31. Weyer C., Bogardus C., and Pratley R.E. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48 (1999) 2197-2203